NCT03916822View on ClinicalTrials.gov

Cell-based Assays for Antibody-mediated Transplant Rejection

UnknownOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

April 15, 2019

Primary Completion Date

June 14, 2021

Study Completion Date

August 14, 2021

Conditions
Antibody-Mediated Graft Rejection
Interventions
DIAGNOSTIC_TEST

Alloantigen-specific B-cells

Alloantigen-specific B-cells which express CD154 and their subsets which also co-express cytokines, memory and naive markers, and additional derivatives of these markers will be measured with flow cytometry

Trial Locations (2)

14215

NOT_YET_RECRUITING

Erie County Medical Center, Buffalo

29425

RECRUITING

Medical University of South Carolina, Charleston

Sponsors

Lead Sponsor

Plexision
All Listed Sponsors
collaborator

Medical University of South Carolina

OTHER

lead

Plexision

INDUSTRY

NCT03916822 - Cell-based Assays for Antibody-mediated Transplant Rejection | Biotech Hunter | Biotech Hunter